Unlike alot of MM/weed stocks down the spec end and Bio specs, we actually have 2 background revenue streams. Of course there is risk /reward. But alot have NO background revenues. Also many have outlandish corporate costs and management /director fees. Until we see the quarterly reports we are all speculating. ...my self included. Watch the buy side...buyers will turn up at a sniff of positive news........imo.
IHL Price at posting:
7.2¢ Sentiment: Buy Disclosure: Held
